Intelligent Cloud Software for Life Sciences R&D

Drug Development Software

ArisGlobal Recognized by Frost & Sullivan with the 2021 Customer Value Leadership Award


Empowering teams to deliver breakthroughs. Faster.

ArisGlobal’s LifeSphere platform is a suite of unified cloud solutions that helps hundreds of global life sciences companies accelerate development, maintain compliance and streamline collaboration between cross-functional teams. LifeSphere enables the life sciences industry to bring safer products to market more quickly.

Accelerate R&D

Save time and effort by managing the end-to-end R&D process in a single cloud platform with unified data and documents. Native automation streamlines tasks and lets your team focus on what matters most.

Reduce Risk

Scalable cloud architecture delivers continuous innovation and stays up to date with the latest regulatory compliance standards, future-proofing your R&D technology and reducing risk.

Streamline Collaboration

Unified R&D applications that streamline cross-functional collaboration and provide a single source of truth across the entire organization, enabling teams to work together more effectively.

Innovation. Transformation. Breakthrough2021.

Life and health transformed through technology, innovation, and industry leadership.

ArisGlobal’s Breakthrough2021 is a virtual event designed to bring together members of the life sciences industry to discuss innovation and digital transformation trends within R&D.  This year’s event will feature sessions and keynotes delivered by leading voices from the industry, with the goal of sharing best practices, experiences, and ideas. 

Press Release - ArisGlobal LifeSphere eTMF Boosts Collaboration in Clinical Research by Supporting New Trial Master File Standard

ArisGlobal, the leading provider of software that automates core product development functions for over 300 global life sciences companies, today released one of the first electronic Trial Master File systems to support a groundbreaking new data standard.

ArisGlobal News - Important Update Regarding COVID-19 from ArisGlobal President and CEO Sankesh Abbhi

As the global COVID-19 situation evolves, the ArisGlobal team has continued to closely monitor developments and take proactive measures to ensure the continuity of our business operations and services, as well as the wellbeing of our employees.

Webinar: IDMP, Key Engine to a Regulatory Strategy

Regulatory Departments at EU life science companies are finally gearing up for IDMP implementation after years of policy development. IDMP can be considered a framework for investing in the processes and technology to not only achieve compliance, but to also address the end-to-end processes throughout the regulatory lifecycle.

2021 State of the Industry - Automation Trends in Life Sciences R&D

Receive early access to insights on the state of automation in life sciences R&D by contributing to this industry survey. See how your organization ranks and where the industry is headed.

Press Release: Dr. Reddy’s Laboratories Selects LifeSphere® Signal and Risk Management

The leading multination pharmaceutical company plans to use ArisGlobal’s platform to deliver the next generation of integrated signal detection and risk management globally.

Webinar: Vaccine Development and Surveillance in the Age of COVID

Join Linical Americas and ArisGlobal in a joint webinar

Unified Development Platforms: The use cases, benefits and strategies defining the future of life sciences tech

Explore digital transformation in the context of life sciences R&D, focusing specifically on the concept of a unified drug development technology platform.

Top Five BioPharma Adopts LifeSphere MultiVigilance to Automate Drug Safety

A global life sciences leader will deploy ArisGlobal’s next-generation safety system, leveraging cognitive automation to streamline case processing.


The LifeSphere® Platform








Medical Affairs



LifeSphere Clinical is a cloud platform for clinical operations and data management that accelerates studies, ensures transparency and streamlines collaboration across your organization.

Key Products



LifeSphere Regulatory delivers end-to-end regulatory information management in an all-new, fully unified cloud platform that accelerates speed to market, enhances data quality and streamlines collaboration across teams.

Key Products

LifeSphere Medical Information



LifeSphere Safety is an end-to-end platform that helps hundreds of pharmacovigilance teams around the world save time and effort, ensure future-proof compliance and unlock deep insights from safety data.

Key Products

LifeSphere MultiVigilance


Medical Affairs

LifeSphere Medical Affairs is a cloud platform that helps life sciences organizations deliver timely information, stay compliant and streamline collaboration between global stakeholders.

Key Products

LifeSphere Medical Information



LifeSphere EasyDocs is a cloud content and document management application that gives R&D teams one central location for managing information, delivering efficiency, compliance, and enhanced collaboration across drug development workflows.

LifeSphere EasyDocs seamlessly connects with R&D applications for a truly unified experience.

LifeSphere Medical Information

We’re Hiring!

Join the team and make your impact in life sciences. Check out all the open roles across engineering, sales, marketing, and other departments

Partnering With the Industry’s Best

Advanced technology, such as artificial intelligence and machine learning, are key LifeSphere MultiVigilance capabilities that help us automate repetitive, manual tasks, thus improving efficiency and compliance. By switching to LifeSphere MultiVigilance, our efforts to comply with regulations will be much more efficient.


“Our decision to upgrade to LifeSphere MultiVigilance was based on better integration, improved case management, reduced costs, and the ability to reach even higher compliance requirements of our customers and regulators.”

Ravi Menon
Chairman of the Board


“We have seen how the LifeSphere platform’s advanced robotic automation and cognitive features will allow us to automate many of our key PV steps in the area of case processing, which are currently resource intensive”

Claudia Lehmann
Head of PV Operations

Delivering Real Results to a Global Client Base



Of Top 50 Biopharmas

80% of the top 50 biopharma companies are our clients



Efficiency Gains

80% potential efficiency gains driven by our Nava cognitive computing engine



Cost Savings

30% immediate cost savings potential via our advanced automation capabilities




100% compliance with all present and upcoming regulatory standards

News and Events

Industry Perspectives:
Concept of Smart ICSRs.

As the Biopharmaceutical Industry moves towards the digitalization of the R&D landscape, the classical way of doing Pharmacovigilance will have to change. It is now widely accepted that we cannot wish away ICSRs. Organizations will have to move towards the concept of ‘’Smart ICSRs’’.

Delivering on the Promise of Automation in Pharmacovigilance

A Time Study Measuring Case Processing Efficiency Gains from a Next-Generation Safety System

New Regulatory Capabilities Position ArisGlobal for Future Growth, Report Says

 ArisGlobal Recognized in Gens & Associates “RIM Software Provider Landscape” February 2021, Market Report Miami, FL. April 6th, 2021 – ArisGlobal, the leading provider of software that automates core product development functions for over 300 global life sciences.

Dr. Reddy’s Laboratories Selects LifeSphere® Signal and Risk Management

 Dr. Reddy’s Laboratories Ltd., an integrated global pharmaceutical company committed to providing affordable and innovative medicines for healthier lives, has selected ArisGlobal’s LifeSphere® Signal and Risk Management as the next-generation signal detection and risk management system for its global pharmacovigilance team.

EVERSANA and ArisGlobal announce strategic partnership to transform drug safety automation and advance integrated compliance models

EVERSANA™ and ArisGlobal announced a strategic partnership to digitally transform end-to-end pharmacovigilance services, leading to safer, more effective healthcare for patients worldwide.

Imperial Brands Selects ArisGlobal’s End-to-End LifeSphere® Regulatory Platform

Imperial Brands, a global consumer goods company, has adopted LifeSphere Regulatory as its end-to-end platform for regulatory affairs. With the selection of LifeSphere Regulatory, Imperial Brands gains a unified platform for regulatory information management, document management and publishing, helping them streamline collaboration across teams.

Contact Us

By clicking the ‘submit’ button, you are agreeing to opt-in to communications from ArisGlobal and use of the above information for ArisGlobal products, news & updates. Please note you can unsubscribe to email communication from ArisGlobal any time.

Breakthrough2021: Learn from experts, share best practices, and bring new ideas forward. Register Now